Janet Fairley, MD
Dermatology · Iowa City, IANPI 1023069929
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by AstraZeneca at 55.2% of the total. Reporting peaked in 2020 at $2,140 and has fallen 98.6% since, to $30 in 2025.
Across 15 payments — averaging $258.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Astrazeneca UK Limited$2K
- Regeneron$30
- Sanofi$15
Across 17 payments — averaging $5061.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$44K
- Astrazeneca UK Limited$32K
- Novartis$11K
What the payments were for
- Consulting fees$2,14055%
- Travel & lodging$1,32234%
- Food & beverage$41211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $2,140 |
| Astrazeneca UK Limited | 10 | $1,689 |
| Regeneron | 1 | $30 |
| Sanofi | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$1,419
How this compares
$3,874 in reported general payments places this provider in the 75th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Iowa City
- Ali JabbariIowa City$38K
- Kevin CheungIowa City$2K
- Deborah Huebbe YouhnIowa City$2K
- Sarah MinionIowa City$838
- Heather CilibertoIowa City$789
- Roshan AbidIowa City$716
- Laura Correa FerrerIowa City$555
- Carmine PalladinoIowa City$546
- Samuel PalmerIowa City$499
- Zakariyah Sharif-SidiIowa City$410
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.